Therapeutic approaches and drug-resistance in chronic lymphocytic leukaemia

The treatment of chronic lymphocytic leukaemia has been revolutionised in recent years, first by the introduction of chemoimmunotherapy regimens and subsequently by the development of drugs, including ibrutinib, idelalisib and venetoclax, that target components of the B-cell receptor signalling path...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Narjis, Crassini, Kyle R., Thurgood, Lauren, Shen, Yandong, Christopherson, Richard I., Kuss, Bryone, Mulligan, Stephen P., Best, Oliver Giles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992478/
https://www.ncbi.nlm.nih.gov/pubmed/35582439
http://dx.doi.org/10.20517/cdr.2019.111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992478/
https://www.ncbi.nlm.nih.gov/pubmed/35582439
http://dx.doi.org/10.20517/cdr.2019.111

Ejemplares similares